Paper37101738
Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial.
Jessen S and 7 others. ERJ Open Res, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial. Papers, record 37101738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37101738
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16432501 | Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16432501 | PubMed |
| 2 | 16061702 | Impact of changes in the IOC-MC asthma criteria: a British perspective. | Thorax | 2005 | https://conductscience.org/library/papers/16061702 | PubMed |
| 3 | 17433829 | American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. | J Allergy Clin Immunol | 2007 | https://conductscience.org/library/papers/17433829 | PubMed |
| 4 | 11558866 | A systematic review of the associations between dose regimens and medication compliance. | Clin Ther | 2001 | https://conductscience.org/library/papers/11558866 | PubMed |
| 5 | 30819762 | Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β 2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies. | J Pharmacol Exp Ther | 2019 | https://conductscience.org/library/papers/30819762 | PubMed |
| 6 | 10647532 | Limiting factors for maximum oxygen uptake and determinants of endurance performance. | Med Sci Sports Exerc | 2000 | https://conductscience.org/library/papers/10647532 | PubMed |
| 7 | 9506248 | Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma. | Drugs | 1998 | https://conductscience.org/library/papers/9506248 | PubMed |
| 8 | 10197228 | A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. | Respir Med | 1998 | https://conductscience.org/library/papers/10197228 | PubMed |
| 9 | 9893769 | Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. | Respir Med | 1998 | https://conductscience.org/library/papers/9893769 | PubMed |
| 10 | 24100289 | Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists. | Br J Sports Med | 2015 | https://conductscience.org/library/papers/24100289 | PubMed |
| 11 | 24451697 | The ergogenic effect of long-term use of high dose salbutamol. | Clin J Sport Med | 2014 | https://conductscience.org/library/papers/24451697 | PubMed |
| 12 | 11453313 | Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes. | Respir Med | 2001 | https://conductscience.org/library/papers/11453313 | PubMed |
| 13 | 27375484 | Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/27375484 | PubMed |
| 14 | 15734875 | Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density. | Am J Physiol Heart Circ Physiol | 2005 | https://conductscience.org/library/papers/15734875 | PubMed |
| 15 | 33210444 | Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control. | Drug Test Anal | 2021 | https://conductscience.org/library/papers/33210444 | PubMed |
| 16 | 35169025 | European Respiratory Society guidelines for the diagnosis of asthma in adults. | Eur Respir J | 2022 | https://conductscience.org/library/papers/35169025 | PubMed |
| 17 | 1685013 | Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats. | Naunyn Schmiedebergs Arch Pharmacol | 1991 | https://conductscience.org/library/papers/1685013 | PubMed |
| 18 | 25671256 | Asthma and exercise-induced bronchoconstriction in athletes. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25671256 | PubMed |
| 19 | 31442335 | Effect of beta2 -adrenergic agonist and resistance training on maximal oxygen uptake and muscle oxidative enzymes in men. | Scand J Med Sci Sports | 2019 | https://conductscience.org/library/papers/31442335 | PubMed |
| 20 | 30978146 | Racing weight and resistance training: perceptions and practices in trained male cyclists. | Phys Sportsmed | 2019 | https://conductscience.org/library/papers/30978146 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42548751 | Prevalence of self-reported asthma among female ice hockey players in the Swedish women's hockey league. | Front Sports Act Living | 2026 | https://conductscience.org/library/papers/42548751 | PubMed |
| 41582615 | Fibre Type-Specific Proteomics Reveals Shared and Distinct Skeletal Muscle Adaptations to Resistance Training and Beta2-Adrenergic Agonist. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/41582615 | PubMed |
| 40946331 | Clenbuterol induces lean mass and muscle protein accretion, but attenuates cardiorespiratory fitness and desensitizes muscle β2-adrenergic signalling. | J Physiol | 2025 | https://conductscience.org/library/papers/40946331 | PubMed |
| 39148405 | Beta2-adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration. | Drug Test Anal | 2025 | https://conductscience.org/library/papers/39148405 | PubMed |
| 38152086 | Inhaled salbutamol induces leanness in well-trained healthy females but not males during a period of endurance training: a randomised controlled trial. | ERJ Open Res | 2023 | https://conductscience.org/library/papers/38152086 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CS | 1431 | PubTator's text mining | https://conductscience.org/library/genes/1431 | NCBI Gene |
| HADH | 3033 | PubTator's text mining | https://conductscience.org/library/genes/3033 | NCBI Gene |
| IGKV5-2 | 28907 | PubTator's text mining | https://conductscience.org/library/genes/28907 | NCBI Gene |
| MLIP | 90523 | PubTator's text mining | https://conductscience.org/library/genes/90523 | NCBI Gene |
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37101738
GET https://conductscience.org/api/papers/v1/37101738/references?page=2